Sriveda Boyalakuntla/LinkedIn
Jan 4, 2026, 21:39
Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
Sriveda Boyalakuntla, Volunteer at Mass General Hospital, shared on LinkedIn:
”Grateful for the opportunity to attend ASH25 and present our work on abbreviated DOAC therapy for pediatric infection-associated cerebral venous sinus thrombosis.
I’m honored to have received an Abstract Achievement Award for this work.
A huge thank you to Dr. Riten Kumar for the incredible mentorship and guidance throughout this project without whose support this experience would not be possible.
I learned so much from the conference, listening to experts in hematology, meeting inspiring professionals, and engaging with the hematology community.
I’m excited to carry these insights forward in my future endeavors.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 04:57Ahmed Elsobky: Strengthening Hemophilia Care Under Egypt’s Universal Health Insurance System
-
May 24, 2026, 04:49Hussien Hishmat: There Is More to Pulmonary Embolism than Just Anticoagulation
-
May 24, 2026, 04:25Sarah Elkourashy: Diagnostic Challenges and Management Strategies for Maternal–Fetal Outcomes in TTP
-
May 24, 2026, 04:11Ayah Ghazi Al-Qasrawi: How Should Sepsis-Induced DIC Be Managed in Patients Receiving Thienopyridines
-
May 24, 2026, 04:05Kate Hayward: Recent Stroke Recovery and Rehabilitation Highlights
-
May 24, 2026, 03:33Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
-
May 24, 2026, 03:33Lucia Mazzolai: Systemic Vascular Approach to Peripheral Artery Disease
-
May 24, 2026, 03:32Isaac Okello: Africa CDC Launches Continental Framework for Sickle Cell Disease
-
May 24, 2026, 03:32Karine Kocharian: Advancing Hemophilia Care Equity at the 79th World Health Assembly